MMJ Group Holdings Limited (ASX:MMJ) (OTCMKTS:MMJJF) is holding a shareholders' meeting on 22 February 2019 to approve, amongst other matters, an equity raising pursuant to a share purchase plan.
MMJ Group Holdings Limited (ASX:MMJ) (OTCMKTS:MMJJF) is delighted to note that Fire & Flower Inc. (CVE:FAF) listed on the TSX Venture Exchange with its shares closing at CAD1.34 compared to MMJ's entry cost of CAD0.80.
Anatara Lifesciences Ltd (ASX:ANR) is pleased to release its Appendix 4D financial report for the half year ending 31st December 2018.
Anatara Lifesciences (ASX:ANR) is pleased to release a copy of the presentation that Chief Executive Officer, Mr Steven Lydeamore, will be presenting at the Proactive Investors Australia CEO Sessions and the Wholesale Investor's Emergence 2019 conferences this month.
MMJ Group Holdings Limited (ASX:MMJ) (FRA:2P9) (OTCMKTS:MMJJF) is pleased to announce that it has commit-ted to invest AUD1 million of ordinary equity for a 10% ownership interest in Trichomia Pty Limited.
MMJ Group Holdings Limited (ASX:MMJ) (FRA:2P9) (OTCMKTS:MMJJF) attaches a copy of a recent news release by MediPharm Labs Inc ("MediPharm Labs") (CVE:LABS) (OTCMKTS:MLCPF) announcing that MediPharm Labs signed a CAD35m private label cannabis oil sale agreement with an option for additional CAD13.5m.
This month, Anatara's CEO, Steve Lydeamore will be presenting to investors at events in Sydney and Melbourne. We would like to extend to you the invitation to attend.
